Skip to main content Accessibility help
×
Hostname: page-component-78c5997874-g7gxr Total loading time: 0 Render date: 2024-11-03T09:15:46.614Z Has data issue: false hasContentIssue false

11 - Neutrophil–Endothelial Cell Interactions

from PART II - INDIVIDUAL CELL TYPES

Published online by Cambridge University Press:  05 April 2014

János G. Filep
Affiliation:
University of Montreal and Research Center
Sean P. Colgan
Affiliation:
University of Colorado Health Sciences Center
Charles N. Serhan
Affiliation:
Harvard Medical School
Peter A. Ward
Affiliation:
University of Michigan, Ann Arbor
Derek W. Gilroy
Affiliation:
University College London
Get access

Summary

INTRODUCTION

Neutrophils (polymorphonuclear leukocytes, PMN) have a clearly defined role in inflammation. In response to injury or infection, PMN migration across vascular endothelial cells is a first line of defense against infectious agents, and defects in such PMN–endothelial interactions contributes to fulminate microbial infections, mucosal ulcerations, and delayed tissue healing. The protective aspects of PMN in disease are objectively exemplified by the clinical observation that patients with primary defects in PMN function, including neutropenia and genetic PMN immunopathologies (e.g., leukocyte adhesion deficiencies, chronic granulomatous disease, Chediak–Higashi syndrome, myeloperoxidase deficiency, etc.), exhibit ongoing mucosal infections.

This chapter focuses on our current understanding of how PMN interact with vascular endothelial cells under physiologic and pathophysiologic conditions (Figure 11.1).

MOLECULAR MECHANISMS OF PMN ADHESION AND TRANSMIGRATION

PMN migration across the endothelial surface is a result of an orchestrated series of events, ultimately resulting in PMN accumulation at sites of tissue injury. The recruitment signals, the cell–cell interaction steps, and the regulatory pathways for these events have been an area of extensive exploration in the past two decades. A number of recent reviews have addressed these steps in detail [1 –4]. Here, we will summarize some of the major steps and guide the reader to the primary literature for more insight into this dynamic process.

Type
Chapter
Information
Publisher: Cambridge University Press
Print publication year: 2010

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Ley, K., Laudanna, C., Cybulsky, M.I., and Noursargh, S. 2007. Getting to the site of inflammation: the leu¬kocyte adhesion cascade updated. Nat Rev Immunol 7:678–689.CrossRefGoogle Scholar
2. Yonekawa, K., and Harlan, J.M. 2005. Targeting leukocyte integrins in human diseases. J Leukoc Biol. 77:129–140.CrossRefGoogle ScholarPubMed
3. Smith, C.W. 2008. Adhesion molecules and receptors. J Allergy Clin Immunol 121:S375–379.CrossRefGoogle ScholarPubMed
4. Wagner, D.D., and Frenette, P.S. 2008. The vessel wall and its interactions. Blood 111:5271–5281.CrossRefGoogle Scholar
5. Weber, C., Fraemohs, L., and Dejana, E. 2007. The role of junctional adhesion molecules in vascular inflammation. Nat Rev Immunol 7:467–477CrossRefGoogle ScholarPubMed
6. Gimbrone, M.A., Nagel, T., and Topper, J.N. 1997. Biomechanical activation: an emerging paradigm in endothelial adhesion biology. J Clin Invest 99: 1809–1813.CrossRefGoogle ScholarPubMed
7. Schottelius, A.J., Mayo, M.W., Sartor, R.B., and Baldwin, A.S. Jr. 1999. Interleukin-10 signaling blocks inhibitor of κB kinase activity and nuclear factor κB DNA binding. J Biol Chem 274:31868–31874.CrossRefGoogle ScholarPubMed
8. Francis, S.E., Camp, N.J., Dewberry, R.M., et al. 1999. Interleukin-1 receptor antagonist gene polymorphism and coronary artery disease. Circulation 99:861–866.CrossRefGoogle ScholarPubMed
9. Otterbein, L.E., Kolls, J.K., Mantell, L.L., Cook, J.L., Alam, J., and Choi, A.M. 1999. Exogenous administration of heme oxygenase-1 by gene transfer provides protection against hyperoxia-induced lung injury. J Clin Invest 103:1047–1054.CrossRefGoogle ScholarPubMed
10. Yachie, A., Niida, Y., Wada, T., et al. 1999. Oxidative stress causes enhanced endothelial cell injury in human heme oxygensae-1 deficiency. J Clin Invest 103:129–135.CrossRefGoogle ScholarPubMed
11. Choi, E.Y., Chavakis, E., Czabanka, M.A., et al. 2008. Del-1, an endogenous leukocyte-endothelial cell adhesion inhibitor, limits inflammatory cell recruitment. Science 322:1101–1104.CrossRefGoogle ScholarPubMed
12. Colgan, S.P., Eltzschig, H.K., Eckle, T., and Thompson, L.F. 2006. Physiologic roles for ecto-5'-nucleotidase (CD73). Purinergic Signal 2:351–360.CrossRefGoogle Scholar
13. Robson, S.C., Sevigny, J., and Zimmermann, H. 2006. The E-NTPDase family of ectonucleotidases: structure function relationships and pathophysiological significance. Purinergic Signal 2:409–430.CrossRefGoogle ScholarPubMed
14. Eltzschig, H.K., Macmanus, C.F., and Colgan, S.P. 2008. Neutrophils as sources of extracellular nucleotides: functional consequences at the vascular interface. Trends Cardiovasc Med 18:103–107.CrossRefGoogle ScholarPubMed
15. Wehrle-Haller, B., and Imhof, B.A. 2003. Integrindependent pathologies. J Pathol 200:481–487.Google ScholarPubMed
16. Mayadas, T.N., and Cullere, X. 2005. Neutrophil |B2 integrins: moderators of life or death decisions. Trends Immunol 26:388–395.CrossRefGoogle ScholarPubMed
17. Millan, J., Hewlett, L., Glyn, M., Toomre, D., Clark, P., and Ridley, A.J. 2006. Lymphocyte transcellular migration occurs through recruitment of endothelial ICAM-1 to caveola- and F-actin-rich domains. Nat Cell Biol 8:113–123.CrossRefGoogle ScholarPubMed
18. Serhan, C.N., Chiang, N., and Van Dyke, T. E. 2008. Resolving inflammation: dual antiinflammatory and pro-resolution lipid mediators. Nat Rev Immunol 8: 349–361.CrossRefGoogle Scholar
19. Ulbrich, H., Eriksson, E.E., and Lindbom, L. 2003. Leukocyte and endothelial cell adhesion molecules as targets for therapeutic interventions in inflammatory diseases. Trends Pharmacol Sci 24:640–647.CrossRefGoogle Scholar
20. Gilroy, D.W., Lawrence, T., Perretti, M., and Rossi, A.G. 2004. Inflammatory resolution: new opportunities fro drug discovery. Nat Rev Drug Discov 2:965–975.Google Scholar
21. Yonekawa, K., and Harlan, J.M. 2005. Targeting leukocyte integrins in human diseases. J Leukoc Biol 77:129–140.CrossRefGoogle ScholarPubMed
22. Gordon, K.B., Papp, K.A., Hamilton, T.K., et al. 2003. Efalizumab for patients with moderate to severe plaque psoriasis: a randomized controlled trial. JAMA 290:3073–3080.CrossRefGoogle ScholarPubMed
23. Keeley, K.A., Rivey, M.P., and Allington, D.R. 2005. Natulizimab for the treatment of multiple sclerosis and Crohn's disease. Ann Pharmacother 39:1833–1843.CrossRefGoogle ScholarPubMed
24. Rivera-Nieres, J., Gorfu, , and Ley, K. 2008. Leukocyte adhesion models of inflammatory bowel disease. Inflamm Bowel Dis 14:1715–1735.Google Scholar
25. El Kebir., D., József, L., Pan, W., and Filep, J.G. 2008. Myeloperoxidase delays neutrophil apoptosis through CD11b/CD18 integrins and prolongs inflammation. Circ Res 103:352–359.CrossRefGoogle ScholarPubMed
26. Rossi, A.G., Sawatzky, D.A., Walker, A., et al. 2006. Cyclin-dependent kinase inhibitors enhance the resolution of inflammation by promoting inflammatory cell apoptosis. Nat Med 12:1056–1064.Google ScholarPubMed
27. ElKebir, D., József, L., Pan, W., Petasis, N.A., Serhan, C.N., and Filep, J.G. 2007. Aspirin-triggered lipoxins override the apoptosis-delaying action of serum amyloid A in human neutrophils: a novel mechanism for resolution of inflammation. J Immunol 179:616–622.Google Scholar
Butcher, E.C. 1991. Leukocyte-endothelial cell recognition: three (or more) steps to specificity and diversity. Cell 67:1033–1036.CrossRefGoogle ScholarPubMed
Jacobson, K.A., and Gao, Z.G. 2006. Adenosine receptors as therapeutic targets. Nat Rev Drug Discov 5:247–264.CrossRefGoogle ScholarPubMed
Kong, T., Eltzschig, H.K., Karhausen, J., Colgan, S.P., and Shelley, C.S. 2004. Leukocyte adhesion during hypoxia is mediated by HIF-1-dependent induction of β2 integrin gene expression. Proc Nat Acad Sci USA 101:10440–10445.CrossRefGoogle ScholarPubMed
Rao, R.M., Yang, L., Garcia-Cardena, G., and Luscinskas, F.W. 2007. Endothelial-dependent mechanisms of leukocyte recruitment to the vascular wall. Circ Res 101:234-247CrossRefGoogle ScholarPubMed
Serhan, C.N., Brain, S.D., Buckley, C.D., et al. 2007. Resolution of inflammation: state of the art, definitions and terms. FASEB J 21:325–332.CrossRefGoogle ScholarPubMed
Tedgui, A., and Mallat, Z. 2001. Antiinflammatory mechanisms in the vascular wall. Circ Res 88:877–887.CrossRefGoogle Scholar

Save book to Kindle

To save this book to your Kindle, first ensure [email protected] is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×